1.
Meta-analyses of colorectal cancer risk factors
by Johnson, Constance M
Cancer causes & control, 2013-06-01, Vol.24 (6), p.1207-1222
2.
Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts
by Vasen, Hans F A
Gut, 2013-06, Vol.62 (6), p.812-823
3.
Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer
by Church, Timothy Robert
Gut, 2014-02, Vol.63 (2), p.317-325
4.
5.
Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)
by Cairns, Stuart R
Gut, 2010-05, Vol.59 (5), p.666-689
6.
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42 103 individuals
by Dunlop, Malcolm G
Gut, 2013-06, Vol.62 (6), p.871-881
7.
The consensus molecular subtypes of colorectal cancer
by Guinney, Justin
Nature medicine, 2015, Vol.21 (11), p.1350-1356
8.
9.
Cost-effectiveness of one versus two sample faecal immunochemical testing for colorectal cancer screening
by Goede, S Lucas
Gut, 2013-05, Vol.62 (5), p.727-734
10.
Long noncoding RNAs: Novel players in colorectal cancer
by Han, Dong
Cancer letters, 2015, Vol.361 (1), p.13-21
11.
Long noncoding RNAs: Undeciphered cellular codes encrypting keys of colorectal cancer pathogenesis
by Kim, Taewan
Cancer letters, 2018-03-28, Vol.417, p.89-95
12.
Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
by Logan, Richard F A
Gut, 2012-10, Vol.61 (10), p.1439-1446
13.
Serrated polyposis: rapid and relentless development of colorectal neoplasia
by Edelstein, Daniel L
Gut, 2013-03, Vol.62 (3), p.404-408
14.
Colonoscopy quality measures: experience from the NHS Bowel Cancer Screening Programme
by Lee, Thomas J W
Gut, 2012-07, Vol.61 (7), p.1050-1057
15.
Neoadjuvant immunotherapy leads to pathological responses in MMR-proficient and MMR-deficient early-stage colon cancers
by Chalabi, Myriam
Nature medicine, 2020-04, Vol.26 (4), p.566-576
16.
Long-term risk of colorectal cancer after adenoma removal: a population-based cohort study
by Cottet, Vanessa
Gut, 2012-08, Vol.61 (8), p.1180-1186
17.
TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression
by Sillars-Hardebol, Anke H
Gut, 2012-11, Vol.61 (11), p.1568-1575
18.
Clinicopathological characteristics and survival outcomes for patients with mucinous colorectal cancer liver metastases undergoing hepatic resection: A systematic review and meta-a...
by Reynolds, Ian S
The American journal of surgery, 2021-09, Vol.222 (3), p.529-535
19.
Nottingham trial of faecal occult blood testing for colorectal cancer: a 20-year follow-up
by Scholefield, J H
Gut, 2012-07, Vol.61 (7), p.1036-1040
20.
Epidemiology, management and prognosis of colorectal cancer with lung metastases: a 30-year population-based study
by Mitry, Emmanuel
Gut, 2010-10, Vol.59 (10), p.1383-1388
